Randy H Thurman
CIK 1204059 · Executive Chairman · last filed 2026-05-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TFFP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 2024
CHICAGO, IL 60654
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Director | 5,593 | $0.57 | $3.2K | $2.1K | 6 | 2026-05-27 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 0 | $0.07 | $0 | -$772.6K | 6 | 2022-09-30 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | Director | 11,875 | $0.03 | $356 | $16.5K | 8 | 2021-03-26 |
| Outlook Therapeutics, Inc. (ONSIW) Delisted | Director | — | — | — | $0 | 3 | 2018-11-13 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | Director | — | — | — | $0 | 1 | 2018-04-17 |
| Veradigm Inc. (MDRX) Delisted | Director | 105,014 | $6.81 | $715.1K | $150.8K | 7 | 2017-05-24 |
| LENS | Executive Chairman | 47,757 | $42.64 | $2.04M | $109.5K | 6 | 2017-03-22 |
| OFIX | Director | — | $9.95 | — | $0 | 1 | 2013-11-21 |
| BEAT | Chairman, President & CEO | 264,766 | $0.40 | $105.9K | $99.8K | 10 | 2011-05-03 |
| VIASYS HEALTHCARE INC (VAS) Delisted | Chairman, President & CEO | 51,334 | — | — | $0 | 3 | 2007-06-25 |
Recent Filings · Page 6 of 6
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-08-27 | BEAT | Grant (A) | — | $0 | EDGAR |
| 2008-07-09 | BEAT | Grant (A) | — | $0 | EDGAR |
| 2007-07-05 | — | Mixed | −51,334 | -$29.27M | |
| 2007-06-25 | VIASYS HEALTHCARE INC (VAS) Delisted | U | −30,917 | -$1.32M | EDGAR |
| 2007-03-05 | VIASYS HEALTHCARE INC (VAS) Delisted | Mixed | +19,810 | -$161.1K | EDGAR |
| 2007-02-14 | VIASYS HEALTHCARE INC (VAS) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.